Clinical Trials Logo
  1. Home
  2. Hypotrichosis
  3. NCT01448525

Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence

Hypotrichosis Clinical Trial

Clinical Trial Summary

The purpose of this study is to determine patient satisfaction with LATISSE® treatment for increasing eyelash prominence.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01448525
Study type Interventional
Source Allergan
Contact
Status Completed
Phase Phase 4
Start date October 2011
Completion date April 2012
View Details
See also
  Status Clinical Trial Phase
Completed NCT00958035 - Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis Phase 4
Completed NCT01891487 - Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Thinning Eyebrows Phase 4
Completed NCT01387906 - Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo Phase 4
Recruiting NCT05790941 - Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation Early Phase 1
Recruiting NCT05723198 - A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata Phase 3
Completed NCT01200251 - Study of Bimatoprost Gel on Eyelash Growth Phase 3
Completed NCT00907426 - Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin Phase 3